Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
M.B.B.S, MACG, M.D (Gastroenterology), MRCP-1
Family Physician
M.B.B.S., PGD Evidence Based Medicine (EBM), Ph.D Immunology (UK), DFM (Diploma Family Medicine)
Family Physician
M.B.B.S., PGD Evidence Based Medicine (EBM), Ph.D Immunology (UK), DFM (Diploma Family Medicine)
Internal Medicine Specialist
M.B.B.S., M.C.P.S. (Family Medicine), Postgraduate Diploma in Cardiology
Internal Medicine Specialist
M.B.B.S., M.C.P.S. (Family Medicine), Postgraduate Diploma in Cardiology
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S
Hepatologist
Fellow Of American College Of Gastroenterology, MBBS, MRCP (UK), FRCP (Edin)
Hepatologist
Fellow Of American College Of Gastroenterology, MBBS, MRCP (UK), FRCP (Edin)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.(Medicine), M.C.P.S
Internal Medicine Specialist
M.B.B.S., M.C.P.S, F.C.P.S.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures